Literature DB >> 23842849

Cutaneous drug reactions in children: an update.

Kara Heelan1, Neil H Shear.   

Abstract

Cutaneous drug reactions account for a large proportion of adverse drug reactions. Cutaneous drug reactions can be very challenging to diagnose. They can mimic many other skin diseases; this is especially evident during childhood, when viral exanthems are commonplace. Also, if a patient is taking numerous medications, establishing causality to a specific drug can be multifaceted and difficult. The purpose of this review is to highlight an approach to the diagnosis of a suspected cutaneous drug reaction in a child. We have classified different types of drug eruptions by morphology: exanthematous, urticarial, pustular, and bullous. Within each of these groups we have divided them into simple, benign, or non-febrile and complex or febrile reactions. We also include a miscellaneous group to ensure a methodical review.

Entities:  

Mesh:

Year:  2013        PMID: 23842849     DOI: 10.1007/s40272-013-0039-z

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  96 in total

1.  Active monitoring of adverse drug reactions in children. Italian Paediatric Pharmacosurveillance Multicenter Group.

Authors:  G Menniti-Ippolito; R Raschetti; R Da Cas; C Giaquinto; L Cantarutti
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 2.  Rates of cutaneous reactions to drugs.

Authors:  M Bigby
Journal:  Arch Dermatol       Date:  2001-06

3.  Childhood pemphigus associated with montelukast administration.

Authors:  P Cetkovská; K Pizinger
Journal:  Clin Exp Dermatol       Date:  2003-05       Impact factor: 3.470

4.  Acute generalized exanthematous pustulosis in children.

Authors:  Sibel Ersoy; Amy S Paller; Anthony J Mancini
Journal:  Arch Dermatol       Date:  2004-09

Review 5.  Pediatric dermatology emergencies.

Authors:  Douglas W Kress
Journal:  Curr Opin Pediatr       Date:  2011-08       Impact factor: 2.856

6.  Characterization of an anaphylactoid reaction to omalizumab.

Authors:  David H Dreyfus; Christopher C Randolph
Journal:  Ann Allergy Asthma Immunol       Date:  2006-04       Impact factor: 6.347

7.  Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.

Authors:  E B Hunter; P E Johnston; G Tanner; C W Pinson; J A Awad
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

8.  Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.

Authors:  B De Silva; L Banney; W Uttley; R Luqmani; O Schofield
Journal:  Pediatr Dermatol       Date:  2000 Nov-Dec       Impact factor: 1.588

9.  Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis.

Authors:  B A Lang; L A Finlayson
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

10.  Clinical pattern of cutaneous drug eruption among children and adolescents in north India.

Authors:  V K Sharma; S Dhar
Journal:  Pediatr Dermatol       Date:  1995-06       Impact factor: 1.588

View more
  3 in total

1.  Demographic and clinical characteristics of patients with serum sickness-like reaction.

Authors:  Alaaddin Yorulmaz; Fatih Akın; Ahmet Sert; Mehmet Akif Ağır; Rıza Yılmaz; Şükrü Arslan
Journal:  Clin Rheumatol       Date:  2017-08-09       Impact factor: 2.980

Review 2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

3.  Mild cutaneous reactions to drugs.

Authors:  Giuseppe Crisafulli; Fabrizio Franceschini; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Francesca Saretta; Roberto Bernardini; Fabio Cardinale; Francesca Mori; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.